Daren Bergman
Podiatrist · Framingham, MANPI 1669402905
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Treace Medical Concepts, Inc. accounts for 84.3% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $10,925, more than ten times the $52 reported in 2019. Among podiatrist clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $285.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$13K
- Arthrex$1K
- Kairos Surgical Inc$399
- Stryker$380
- Bioventus LLC$46
- Smith+Nephew$28
- plus $53 from 2 others
What the payments were for
- Consulting fees$7,65051%
- Travel & lodging$4,49730%
- Food & beverage$1,76412%
- Education$1,2258%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 30 | $12,753 |
| Arthrex | 5 | $1,478 |
| Kairos Surgical Inc | 5 | $399 |
| Stryker(2 entities) | 8 | $380 |
| Bioventus LLC | 2 | $46 |
| Smith+Nephew | 1 | $28 |
| Organogenesis Inc. | 1 | $28 |
| Osteomed LLC | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LAPIPLASTY SYSTEM 1$9,589
- Lapiplasty System$1,681
- Lapiplasty$798
- PRIME SERIES$113
How this compares
$15,136 in reported general payments places this provider in the 90th percentile of 179 podiatrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 33 | $171 |
| Oxycodone Hcl | 17 | $80 |
| Cephalexin | 17 | $64 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Framingham
- Donald AdamsFramingham$7K
- Viet DieuFramingham$2K
- Pasquale CancelliereSomerville$374K
- Michael TheodoulouSomerville$210K
- Sara Rose-SauldWaltham$92K
- Jonathan KaplanWellesley$56K
- Thanh DinhBoston$48K
- Melissa RicciMilton$46K
- Jeffrey PantanoMilton$46K
- Barry RosenblumBoston$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.